Introduction {#bjs10728-sec-0005}
============

Oesophageal cancer is the sixth leading cause of cancer‐related mortality, and its incidence continues to increase every year[1](#bjs10728-bib-0001){ref-type="ref"}. According to international guidelines[2](#bjs10728-bib-0002){ref-type="ref"}, oesophagectomy is the cornerstone of curative treatment for non‐metastasized oesophageal cancer, often combined with neoadjuvant or perioperative chemo(radio)therapy. Improvement in surgical techniques, perioperative management and patient selection have resulted in a reduction in postoperative mortality after oesophagectomy[3](#bjs10728-bib-0003){ref-type="ref"}. However, anastomotic leakage remains relatively common, and is a major cause of morbidity and mortality. The percentage of patients with anastomotic leakage varies from 6 to 41 per cent[4](#bjs10728-bib-0004){ref-type="ref"}, [5](#bjs10728-bib-0005){ref-type="ref"}, [6](#bjs10728-bib-0006){ref-type="ref"}, [7](#bjs10728-bib-0007){ref-type="ref"}, [8](#bjs10728-bib-0008){ref-type="ref"}.

Several factors are associated with an increased risk of anastomotic leakage, including patient‐related characteristics[5](#bjs10728-bib-0005){ref-type="ref"}, [9](#bjs10728-bib-0009){ref-type="ref"}, [10](#bjs10728-bib-0010){ref-type="ref"}, intraoperative factors[11](#bjs10728-bib-0011){ref-type="ref"}, [12](#bjs10728-bib-0012){ref-type="ref"}, [13](#bjs10728-bib-0013){ref-type="ref"}, postoperative factors and surgical technique[14](#bjs10728-bib-0014){ref-type="ref"}, [15](#bjs10728-bib-0015){ref-type="ref"}, [16](#bjs10728-bib-0016){ref-type="ref"}. Controversy remains about the optimal anatomical location of the oesophagogastric anastomosis (intrathoracic *versus* cervical) after oesophagectomy. Several retrospective studies and one RCT reported increased leak rates in patients with a cervical anastomosis[9](#bjs10728-bib-0009){ref-type="ref"}, [17](#bjs10728-bib-0017){ref-type="ref"}, [18](#bjs10728-bib-0018){ref-type="ref"}. Other studies, including three RCTs[19](#bjs10728-bib-0019){ref-type="ref"}, [20](#bjs10728-bib-0020){ref-type="ref"}, [21](#bjs10728-bib-0021){ref-type="ref"}, did not show a statistically significant difference in leak rates. Some surgeons accept a possible higher leak rate associated with a cervical anastomosis, because a wider oncological resection margin can be achieved. Furthermore, in patients with an anastomotic leak, the sequela may be less severe for a cervical anastomosis than for an intrathoracic anastomosis[22](#bjs10728-bib-0022){ref-type="ref"}. Others advocate that an intrathoracic anastomosis is associated with a lower leak rate because the gastric tube is shorter and better vascularized[9](#bjs10728-bib-0009){ref-type="ref"}.

The scientific evidence for an association between the location of the anastomosis and risk of anastomotic leakage, postoperative morbidity and positive oncological resection margins after oesophagectomy is equivocal. Therefore, the primary aim of this study was to assess anastomotic leakage rates, postoperative morbidity and radical resection rates after oesophageal resection with either an intrathoracic or cervical oesophagogastric anastomosis. A secondary objective was to identify predictors of anastomotic leakage.

Methods {#bjs10728-sec-0006}
=======

All patient data were obtained from the Dutch Upper Gastrointestinal Cancer Audit (DUCA), a registry of all patients undergoing surgery with curative intent for oesophageal or gastric cancer in the Netherlands. The DUCA is a subdivision of the Dutch Institute for Clinical Auditing, founded in 2011, with the objective to facilitate and organize the initiation of nationwide auditing in a uniform format. The DUCA collects data to monitor national guideline adherence and to provide surgical teams with reliable information on outcome measures. Participation is mandatory for all Dutch hospitals performing oesophageal resections, and data are registered for each patient during the hospital stay and until 30 days after discharge. Detailed descriptions of definitions used in the DUCA are provided in an online registry program to stimulate uniform data registration. An independent monitoring team audits the data to evaluate completeness and concordance. The organization of the DUCA has been described in more detail previously[23](#bjs10728-bib-0023){ref-type="ref"}.

Patients {#bjs10728-sec-0007}
--------

All patients undergoing oesophagectomy for oesophageal cancer with gastric tube reconstruction between January 2011 and December 2015 were included. For the comparison between intrathoracic and cervical anastomoses, transhiatal resections were excluded because an intrathoracic anastomosis was never performed during this approach. All proximal tumours were also excluded because a cervical anastomosis is constructed in patients with a proximal tumour. To assess factors associated with anastomotic leakage, all patients were studied.

Treatment {#bjs10728-sec-0008}
---------

Surgical treatment consisted of an open (both abdomen and chest), hybrid (abdomen minimally invasive and open chest) or totally minimally invasive transthoracic oesophagectomy followed by gastric tube construction with a cervical or intrathoracic anastomosis. Details of anastomotic techniques (stapled *versus* handsewn, end‐to‐side *versus* side‐to‐side) are not specified in the DUCA. Patients received neoadjuvant treatment according to national guidelines.

Outcome measures {#bjs10728-sec-0009}
----------------

Patient and treatment‐related characteristics were extracted from the DUCA. Histopathological, surgical and short‐term oncological outcomes were analysed. Surgical outcome parameters included: clinical or radiological anastomotic leakage, pulmonary complications, recurrent nerve paresis, surgical reintervention under general anaesthesia, duration of hospital stay, duration of ICU stay, mortality within 30 days after surgery and/or in‐hospital death, readmissions within 30 days after discharge, positive resection margin and number of retrieved lymph nodes.

Statistical analysis {#bjs10728-sec-0010}
--------------------

Patient and treatment‐related characteristics are described as count with percentages, mean(s.d.) or median (range), as appropriate. Missing values were encountered in 217 patients for eight variables; the percentage of missing values per variable was limited (range 0·0 to 4·9 per variable). It was not possible to recover missing data because patient and hospital identity are concealed in the DUCA. Missing data were considered at random and handled using imputation with the iterative Markov chain Monte Carlo method (5 iterations)[24](#bjs10728-bib-0024){ref-type="ref"}.

To account for the effect of possible confounders on outcomes, propensity score matching was performed for the analysis of intrathoracic *versus* cervical anastomosis. First, propensity scores (the probability, ranging from 0 to 1, that a patient was assigned to an intrathoracic or cervical anastomosis) were derived using a logistic regression model, which included all patient and treatment‐related characteristics presented in *Table* [1](#bjs10728-tbl-0001){ref-type="table-wrap"}. One‐to‐one propensity score matching was performed with nearest‐neighbour matching without replacement, using a calliper width of 0·25 multiplied by the standard deviation of the estimated propensity score[25](#bjs10728-bib-0025){ref-type="ref"}. Balance in measured patient and treatment‐related characteristics of the matched cohort was assessed using standardized mean differences, with differences of less than 10 per cent and close to 0 per cent taken to indicate good balance[26](#bjs10728-bib-0026){ref-type="ref"}. To evaluate the significance of differences between the two treatment groups, the χ^2^ test was used for categorical variables, and the Student\'s *t* test and Mann--Whitney *U* test for continuous variables with a normal and skewed distribution respectively. Logistic regression analysis was used to stratify by type of surgery (open *versus* total minimally invasive approach) in the propensity‐matched cohort by adding an interaction term between surgical approach and anastomotic location for each outcome. For this analysis, hybrid procedures were added to the minimally invasive group.

###### 

Patient and treatment‐related characteristics according to location of the anastomosis, before and after propensity score matching

                                                            Before matching (*n* = 2086)    SMD (%)     After matching (*n* = 1308)    SMD (%)                             
  -------------------------------------------------------- ------------------------------ ------------ ----------------------------- ----------- ------------ ------------ -----
  Age (years)[\*](#bjs10728-note-0002){ref-type="fn"}                                      64·1(9·0)             63·9(8·6)               2·7      64·1(8·9)    64·0(8·3)    2·7
  Sex                                                                    M                 779 (83·9)           835 (72·1)              32·2      526 (80·4)   533 (81·5)   2·9
                                                                         F                 149 (16·1)           323 (27·9)                        128 (19·6)   121 (18·5)  
  BMI (kg/m^2^)[\*](#bjs10728-note-0002){ref-type="fn"}              26·2(4·2)             25·4(4·2)               21·0               26·0(4·2)   26·2(4·2)       1·2      
  ASA fitness grade                                                      I                 150 (16·2)           215 (18·6)               9·0      110 (16·8)   109 (16·7)   5·0
                                                                         II                571 (61·5)           726 (62·7)                        423 (64·7)   408 (62·4)  
                                                                        III                207 (22·3)           212 (18·3)                        121 (18·5)   134 (20·5)  
                                                                         IV                  0 (0)                5 (0·4)                           0 (0)       3 (0·5)    
  COPD                                                                   No                807 (87·0)           1021 (88·2)              3·6      574 (87·8)   568 (86·9)   2·7
                                                                        Yes                121 (13·0)           137 (11·8)                        80 (12·2)    86 (13·1)   
  Coronary artery disease                                                No                830 (89·4)           1063 (91·8)              7·7      593 (90·7)   597 (91·3)   2·0
                                                                        Yes                98 (10·6)             95 (8·2)                          61 (9·3)     57 (8·7)   
  History of myocardial infarction                                       No                861 (92·8)           1102 (95·2)              9·2      616 (94·2)   614 (93·9)   1·2
                                                                        Yes                 67 (7·2)             56 (4·8)                          38 (5·8)     40 (6·1)   
  History of arrhythmia                                                  No                844 (90·9)           1072 (92·6)              5·7      598 (91·4)   598 (91·4)   0·0
                                                                        Yes                 84 (9·1)             86 (7·4)                          56 (8·6)     56 (8·6)   
  Hypertension                                                           No                643 (69·3)           793 (68·5)               1·8      449 (68·7)   449 (68·7)   0·0
                                                                        Yes                285 (30·7)           365 (31·5)                        205 (31·3)   205 (31·3)  
  Peripheral vascular disease                                            No                891 (96·0)           1126 (97·2)              6·3      634 (96·9)   634 (96·9)   0·0
                                                                        Yes                 37 (4·0)             32 (2·8)                          20 (3·1)     20 (3·1)   
  Diabetes mellitus                                                      No                780 (84·1)           1010 (87·2)              8·6      553 (84·6)   561 (85·8)   3·3
                                                                        Yes                148 (15·9)           148 (12·8)                        101 (15·4)   93 (14·2)   
  History of stroke                                                      No                872 (94·0)           1102 (95·2)              5·0      618 (94·5)   615 (94·0)   1·9
                                                                        Yes                 56 (6·0)             56 (4·8)                          36 (5·5)     39 (6·0)   
  Thromboembolic events                                                  No                887 (95·6)           1120 (96·7)              5·5      632 (96·6)   631 (96·5)   0·7
                                                                        Yes                 41 (4·4)             38 (3·3)                          22 (3·4)     23 (3·5)   
  Endocrine disorder                                                     No                895 (96·4)           1113 (96·1)              1·8      630 (96·3)   628 (96·0)   1·7
                                                                        Yes                 33 (3·6)             45 (3·9)                          24 (3·7)     26 (4·0)   
  Previous abdominal or thoracic surgery                                 No                657 (70·8)           822 (71·0)               0·4      470 (71·9)   475 (72·6)   1·7
                                                                        Yes                271 (29·2)           336 (29·0)                        184 (28·1)   179 (27·4)  
  Histology                                                             ADC                814 (87·7)           723 (62·4)              77·0      545 (83·3)   533 (81·5)   5·6
                                                                        SCC                96 (10·3)            392 (33·9)                        92 (14·1)    104 (15·9)  
                                                                       Other                18 (1·9)             43 (3·7)                          17 (2·6)     17 (2·6)   
  Tumour location[†](#bjs10728-note-0003){ref-type="fn"}               Middle               42 (4·5)            319 (27·5)              110·7      42 (6·4)     47 (7·2)    3·7
                                                                       Distal              886 (95·5)           839 (72·5)                        612 (93·6)   607 (92·8)  
  cT category                                                            T1                 49 (5·3)             64 (5·5)                6·4       35 (5·4)     42 (6·4)    0·3
                                                                         T2                190 (20·5)           216 (18·7)                        125 (19·1)   117 (17·9)  
                                                                         T3                665 (71·7)           819 (70·7)                        474 (72·5)   470 (71·9)  
                                                                         T4                 24 (2·6)             59 (5·1)                          20 (3·1)     25 (3·8)   
  cN category                                                            N0                364 (39·2)           370 (32·0)              18·9      230 (35·2)   242 (37·0)   0·4
                                                                         N1                388 (41·8)           503 (43·4)                        283 (43·3)   268 (41·0)  
                                                                         N2                156 (16·8)           238 (20·6)                        125 (19·1)   117 (17·9)  
                                                                         N3                 20 (2·2)             47 (4·1)                          16 (2·4)     27 (4·1)   
  Neoadjuvant therapy                                                    No                 79 (8·5)             95 (8·2)                0·4       50 (7·6)     54 (8·3)    1·3
                                                                        nCT                 52 (5·6)             75 (6·5)                          49 (7·5)     46 (7·0)   
                                                                        nCRT               797 (85·9)           988 (85·3)                        555 (84·9)   554 (84·7)  
  Type of surgery                                                       Open               199 (21·4)           355 (30·7)              22·4      161 (24·6)   170 (26·0)   3·4
                                                                         MI                716 (77·2)           791 (68·3)                        487 (74·5)   479 (73·2)  
                                                                       Hybrid               13 (1·4)             12 (1·0)                          6 (0·9)      5 (0·8)    
  Year of surgery                                                       2015               328 (35·3)           225 (19·4)              61·7      174 (26·6)   164 (25·1)   1·9
                                                                        2014               248 (26·7)           234 (20·2)                        157 (24·0)   178 (27·2)  
                                                                        2013               190 (20·5)           212 (18·3)                        164 (25·1)   135 (20·6)  
                                                                        2012               108 (11·6)           279 (24·1)                        105 (16·1)   125 (19·1)  
                                                                        2011                54 (5·8)            208 (18·0)                         54 (8·3)     52 (8·0)   

Values in parentheses are percentages unless indicated otherwise;

values are mean(s.d.). Patients with proximal tumours and those who underwent a transhiatal resection were excluded from the analysis. All variables presented in *Table* [1](#bjs10728-tbl-0001){ref-type="table-wrap"} were used for propensity matching.

Middle indicates 24--32 cm from teeth, and distal more than 32 cm from teeth. SMD, standardized mean difference; COPD, chronic obstructive pulmonary disease; ADC, adenocarcinoma; SCC, squamous cell carcinoma; nCT, neoadjuvant chemotherapy; nCRT, neoadjuvant chemoradiotherapy; MI, minimally invasive.

The potential association between preoperative patient characteristics and anastomotic leakage was evaluated using univariable analyses in all patients (also including proximal tumours and patients who underwent a transhiatal resection). Variables with *P* \< 0·250 in univariable analysis were entered into a multivariable logistic regression model with backward stepwise selection to determine independent predictors of anastomotic leakage. Multivariable Poisson regression with log link and robust error variance of the final model was used to determine relative risk (RR) estimates with 95 per cent confidence intervals.

Statistical analyses were undertaken using SPSS^®^ version 23.0 (IBM, Armonk, New York, USA), and R 3.1.2 open‐source software with MatchIt and optmatch, sandwich, lmtest and Mice packages (<http://www.r-project.org>). *P* \< 0·050 was considered statistically significant.

Results {#bjs10728-sec-0011}
=======

Of 3348 patients selected for the study, 2086 were included in the comparison between an intrathoracic anastomosis (928) and a cervical anastomosis (1158) (*Fig*. [1](#bjs10728-fig-0001){ref-type="fig"}). Patients were predominantly men (77·4 per cent), and the mean(s.d.) age was 64·6(9·0) years. The percentage of patients with an intrathoracic anastomosis increased during the study interval from 20·6 per cent in 2011 to 59·3 per cent in 2015. Patient and treatment‐related characteristics according to location of the anastomosis are shown in *Table* [1](#bjs10728-tbl-0001){ref-type="table-wrap"}. After propensity matching, 654 patients were included in both groups and all baseline variables including year of surgery were equally distributed (SMD less than 10 per cent).

![Study flow chart](BJS-105-552-g001){#bjs10728-fig-0001}

Intrathoracic versus cervical anastomoses {#bjs10728-sec-0012}
-----------------------------------------

Postoperative complications and pathological data are shown in *Table* [2](#bjs10728-tbl-0002){ref-type="table-wrap"}. Anastomotic leakage was less frequent in patients who underwent an intrathoracic anastomosis than in those with a cervical anastomosis: 111 of 654 (17·0 per cent) *versus* 143 of 654 (21·9 per cent) respectively (*P =* 0·025). Recurrent nerve paresis occurred less often in patients with an intrathoracic anastomosis: 4 of 654 (0·6 per cent) *versus* 46 of 654 (7·0 per cent) respectively (*P* \< 0·001). The median duration of hospital stay was shorter in patients with an intrathoracic anastomosis: 12 (range 3--145) *versus* 14 (4--386) days (*P* \< 0·001). Surgical reinterventions, duration of ICU stay, in‐hospital mortality and number of readmissions were comparable between the two groups. The associations between location of the anastomosis and outcome parameters were not statistically significant when stratified by type of surgical approach (*P* for interaction \> 0·050) (*Table* [2](#bjs10728-tbl-0002){ref-type="table-wrap"}).

###### 

Outcome after oesophagectomy according to location of the anastomosis, before and after propensity score matching

                                                                              Before matching (*n* = 2086)   *P* [‡‡](#bjs10728-note-0013){ref-type="fn"}             After matching (*n* = 1308)              *P* [‡‡](#bjs10728-note-0013){ref-type="fn"}   *P* for interactionby type of surgery[¶¶](#bjs10728-note-0014){ref-type="fn"}                                                     
  -------------------------------------------------------------------------- ------------------------------ ---------------------------------------------- -------------------------------------------------- ---------------------------------------------- ------------------------------------------------------------------------------- -------------------------------------------------- -------
  Anastomotic leakage[†](#bjs10728-note-0006){ref-type="fn"}                                                                                                                     0·230                                                                                                                                                                             0·025                         0·523
  No                                                                                   756 (81·5)                             919 (79·4)                                                                                        543 (83·0)                                                     511 (78·1)                                                                                       
  Yes                                                                                  172 (18·5)                             239 (20·6)                                                                                        111 (17·0)                                                     143 (21·9)                                                                                       
  Pulmonary complications[‡](#bjs10728-note-0007){ref-type="fn"}                                                                                                                 0·688                                                                                                                                                                             0·408                         0·267
  No                                                                                   598 (64·4)                             756 (65·3)                                                                                        421 (64·4)                                                     432 (66·1)                                                                                       
  Yes                                                                                  330 (35·6)                             402 (34·7)                                                                                        233 (35·6)                                                     222 (33·9)                                                                                       
  Recurrent nerve paresis[§](#bjs10728-note-0008){ref-type="fn"}                                                                                                                \< 0·001                                                                                                                                                                          \< 0·001                       0·086
  No                                                                                   924 (99·6)                            1063 (91·8)                                                                                        650 (99·4)                                                     608 (93·0)                                                                                       
  Yes                                                                                   4 (0·4)                                95 (8·2)                                                                                          4 (0·6)                                                        46 (7·0)                                                                                        
  Surgical reintervention[¶](#bjs10728-note-0009){ref-type="fn"}                                                                                                                 0·340                                                                                                                                                                             0·444                         0·055
  No                                                                                   783 (84·4)                             959 (82·8)                                                                                        558 (85·3)                                                     548 (83·8)                                                                                       
  Yes                                                                                  145 (15·6)                             199 (17·2)                                                                                        96 (14·7)                                                      106 (16·2)                                                                                       
  Duration of hospital stay (days)[\*](#bjs10728-note-0005){ref-type="fn"}            12 (3--172)                            14 (3--386)                    \< 0·001[§§](#bjs10728-note-0100){ref-type="fn"}                   12 (3--145)                                                     14 (4--386)                                    \< 0·001[§§](#bjs10728-note-0100){ref-type="fn"}   0·427
  Duration of ICU stay (days)[\*](#bjs10728-note-0005){ref-type="fn"}                  2 (0--125)                             2 (0--155)                     0·024[§§](#bjs10728-note-0100){ref-type="fn"}                      2 (0--125)                                                     2 (0--155)                                      0·123[§§](#bjs10728-note-0100){ref-type="fn"}     0·493
  Postoperative death[\#](#bjs10728-note-0010){ref-type="fn"}                                                                                                                    0·749                                                                                                                                                                             0·458                         0·061
  No                                                                                   889 (95·8)                            1106 (95·5)                                                                                        633 (96·8)                                                     628 (96·0)                                                                                       
  Yes                                                                                   39 (4·2)                               52 (4·5)                                                                                          21 (3·2)                                                       26 (4·0)                                                                                        
  Readmission[\*\*](#bjs10728-note-0011){ref-type="fn"}                                                                                                                          0·991                                                                                                                                                                                                          
  No                                                                                   794 (85·6)                             991 (85·6)                                                                                        556 (85·0)                                                     547 (83·6)                                                          0·494                         0·674
  Yes                                                                                  134 (14·4)                             167 (14·4)                                                                                        98 (15·0)                                                      107 (16·4)                                                                                       
  Positive resection margin[††](#bjs10728-note-0012){ref-type="fn"}                                                                                                              0·497                                                                                                                                                                             0·618                         0·780
  No                                                                                   877 (94·5)                            1102 (95·2)                                                                                        618 (94·5)                                                     622 (95·1)                                                                                       
  Yes                                                                                   51 (5·5)                               56 (4·8)                                                                                          36 (5·5)                                                       32 (4·9)                                                                                        
  No. of lymph nodes harvested                                                                                                                                                   0·752                                                                                                                                                                             0·223                         0·070
  \< 20                                                                                444 (47·8)                             546 (47·2)                                                                                        356 (54·4)                                                     334 (51·1)                                                                                       
  ≥ 20                                                                                 484 (52·2)                             612 (52·8)                                                                                        298 (45·6)                                                     320 (48·9)                                                                                       

Values in parentheses are percentages unless indicated otherwise;

values are median (range).

Any clinically or radiologically proven anastomotic leakage.

Clinically proven pneumonia, pleural effusion leading to drainage, pleural empyema, acute respiratory distress syndrome or reintubation.

Any vocal cord dysfunction after resection.

Any postoperative surgical reintervention under general anesthesia.

Death during initial hospital admission or within 30 days after surgery.

Readmission to hospital within 30 days after initial discharge.

The resection margin was evaluated using the College of American Pathologists criteria[27](#bjs10728-bib-0027){ref-type="ref"}.

χ^2^ test, except

Mann--Whitney *U* test.

Stratified analysis for type of surgery (open approach *versus* minimally invasive approach).

Among patients with an anastomotic leak, there was no significant difference between the anastomosis groups in the percentage of patients who had a surgical reintervention (53·2 per cent of patients with an intrathoracic anastomosis *versus* 44·8 per cent with a cervical anastomosis; *P =* 0·184) or in‐hospital mortality (8·1 *versus* 10·5 per cent respectively; *P =* 0·520). Duration of hospital stay (median 40 (range 9--132) *versus* 28 (4--132) days; *P* \< 0·001) and length of ICU stay (median 8 (1--111) *versus* 4 (1--155) days; *P* = 0·021) were longer after an intrathoracic compared with a cervical anastomotic leak.

Predictors of anastomotic leakage {#bjs10728-sec-0013}
---------------------------------

Some 656 of 3348 patients (19·6 per cent) had an anastomotic leak (*Table* [3](#bjs10728-tbl-0003){ref-type="table-wrap"}, *Fig*. [1](#bjs10728-fig-0001){ref-type="fig"}). The median duration of hospital stay was 26 (range 3--200) days in patients with anastomotic leakage compared with 11 (1--386) days in patients without an anastomotic leak (*P* \< 0·001). Mortality rates were 9·1 and 2·7 per cent respectively (*P =* 0·001).

###### 

Characteristics of 3348 patients with oesophageal cancer according to anastomotic leakage

                                                            No anastomotic leakage (*n* = 2692)[†](#bjs10728-note-0017){ref-type="fn"}   Anastomotic leakage (*n* = 656)[†](#bjs10728-note-0017){ref-type="fn"}   *P* [¶](#bjs10728-note-0020){ref-type="fn"}   Missing data[‡](#bjs10728-note-0018){ref-type="fn"}  
  -------------------------------------------------------- ---------------------------------------------------------------------------- ------------------------------------------------------------------------ --------------------------------------------- ----------------------------------------------------- -----------
  Age (years)[\*](#bjs10728-note-0016){ref-type="fn"}                                                                                                                  64·4(9·1)                                                   65·4(8·5)                                          0·014\#                         11 (0·3)
  Sex                                                                                           M                                                                     2087 (77·5)                                                 519 (79·1)                                           0·379                           1 (0·0)
                                                                                                F                                                                      605 (22·5)                                                 137 (20·9)                                                                         
  BMI (kg/m^2^)[\*](#bjs10728-note-0016){ref-type="fn"}                                     25·9(4·4)                                                                  26·1(4·3)                                                                                                     30 (0·9)                        
  ASA fitness grade                                                                             I                                                                      487 (18·1)                                                  90 (13·7)                                         \< 0·001                         23 (0·7)
                                                                                                II                                                                    1656 (61·5)                                                 369 (56·3)                                                                         
                                                                                               III                                                                     541 (20·1)                                                 191 (29·1)                                                                         
                                                                                                IV                                                                      8 (0·3)                                                     6 (0·9)                                                                          
  COPD                                                                                          No                                                                    2348 (87·2)                                                 540 (82·3)                                           0·001                            0 (0)
                                                                                               Yes                                                                     344 (12·8)                                                 116 (17·7)                                                                         
  Coronary artery disease                                                                       No                                                                    2440 (90·6)                                                 576 (87·8)                                           0·029                            0 (0)
                                                                                               Yes                                                                     252 (9·4)                                                   80 (12·2)                                                                         
  History of myocardial infarction                                                              No                                                                    2522 (93·7)                                                 597 (91·0)                                           0·015                            0 (0)
                                                                                               Yes                                                                     170 (6·3)                                                   59 (9·0)                                                                          
  History of arrhythmia                                                                         No                                                                    2490 (92·5)                                                 582 (88·7)                                           0·002                            0 (0)
                                                                                               Yes                                                                     202 (7·5)                                                   74 (11·3)                                                                         
  Hypertension                                                                                  No                                                                    1840 (68·4)                                                 417 (63·6)                                           0·019                            0 (0)
                                                                                               Yes                                                                     852 (31·6)                                                 239 (36·4)                                                                         
  Peripheral vascular disease                                                                   No                                                                    2593 (96·3)                                                 626 (95·4)                                           0·285                            0 (0)
                                                                                               Yes                                                                      99 (3·7)                                                   30 (4·6)                                                                          
  Diabetes mellitus                                                                             No                                                                    2302 (85·5)                                                 524 (79·9)                                         \< 0·001                           0 (0)
                                                                                               Yes                                                                     390 (14·5)                                                 132 (20·1)                                                                         
  History of stroke                                                                             No                                                                    2535 (94·2)                                                 609 (92·8)                                           0·201                            0 (0)
                                                                                               Yes                                                                     157 (5·8)                                                   47 (7·2)                                                                          
  Thromboembolic events                                                                         No                                                                    2578 (95·8)                                                 630 (96·0)                                           0·756                            0 (0)
                                                                                               Yes                                                                     114 (4·2)                                                   26 (4·0)                                                                          
  Endocrine disorder                                                                            No                                                                    2604 (96·7)                                                 626 (95·4)                                           0·104                            0 (0)
                                                                                               Yes                                                                      88 (3·3)                                                   30 (4·6)                                                                          
  Previous abdominal or thoracic surgery                                                        No                                                                    1881 (69·9)                                                 457 (69·7)                                           0·917                            0 (0)
                                                                                               Yes                                                                     811 (30·1)                                                 199 (30·3)                                                                         
  Histology                                                                                    ADC                                                                    2095 (77·8)                                                 505 (77·0)                                           0·849                          20 (0·6)
                                                                                               SCC                                                                     528 (19·6)                                                 135 (20·6)                                                                         
                                                                                              Other                                                                     69 (2·6)                                                   16 (2·4)                                                                          
  Tumour location[§](#bjs10728-note-0019){ref-type="fn"}                                     Proximal                                                                   28 (1·0)                                                   16 (2·4)                                            0·015                          23 (0·7)
                                                                                              Middle                                                                   312 (11·6)                                                  81 (12·3)                                                                         
                                                                                              Distal                                                                  2352 (87·4)                                                 559 (85·2)                                                                         
  cT category                                                                                   T1                                                                     154 (5·7)                                                   41 (6·3)                                            0·568                          163 (4·9)
                                                                                                T2                                                                     543 (20·2)                                                 126 (19·2)                                                                         
                                                                                                T3                                                                    1896 (70·4)                                                 458 (69·8)                                                                         
                                                                                                T4                                                                      99 (3·7)                                                   31 (4·7)                                                                          
  cN category                                                                                   N0                                                                     986 (36·6)                                                 234 (35·7)                                           0·811                          116 (3·5)
                                                                                                N1                                                                    1131 (42·0)                                                 287 (43·8)                                                                         
                                                                                                N2                                                                     492 (18·3)                                                 118 (18·0)                                                                         
                                                                                                N3                                                                      83 (3·1)                                                   17 (2·6)                                                                          
  Neoadjuvant therapy                                                                           No                                                                     260 (9·7)                                                   73 (11·1)                                           0·062                            0 (0)
                                                                                               nCT                                                                     205 (7·6)                                                   34 (5·2)                                                                          
                                                                                               nCRT                                                                   2227 (82·7)                                                 549 (83·7)                                                                         

Values in parentheses are percentages unless indicated otherwise;

values are mean(s.d.).

Data set after imputation.

Data missing for each variable before imputation.

Proximal indicates less than 24 cm from teeth, middle indicates 24--32 cm from teeth, and distal more than 32 cm from teeth. COPD, chronic obstructive pulmonary disease; ADC, adenocarcinoma; SCC, squamous cell carcinoma; nCT, neoadjuvant chemotherapy; nCRT, neoadjuvant chemoradiotherapy.

χ^2^ test, except \#Student\'s *t* test.

Univariable analysis revealed that anastomotic leakage was associated with several patient‐related factors including age, ASA fitness grade, tumour location and co‐morbidities (*Table* [3](#bjs10728-tbl-0003){ref-type="table-wrap"}). Tumour histology, TNM stage and neoadjuvant therapy did not differ between the groups with or without an anastomotic leak.

Independent predictors of the development of anastomotic leakage included: an ASA grade of III (RR 1·31, 95 per cent c.i. 1·09 to 1·78; *P =* 0·009) or IV (RR 1·98, 1·27 to 3·64; *P =* 0·026), history of chronic obstructive pulmonary disease (COPD) (RR 1·21, 1·02 to 1·45; *P =* 0·031), history of cardiac arrhythmia (RR 1·25, 1·01 to 1·55, *P =* 0·044), diabetes mellitus (RR 1·26, 1·06 to 1·49; *P =* 0·009) and tumour of the proximal oesophagus (RR 1·86, 1·25 to 2·77; *P =* 0·022) (*Table* [4](#bjs10728-tbl-0004){ref-type="table-wrap"}).

###### 

Results of multivariable logistic regression analysis assessing preoperative risk of developing anastomotic leakage after oesophagectomy in 3348 patients with oesophageal cancer

                             Relative risk      *P*
  ----------------------- ------------------- -------
  ASA fitness grade                           
  I                        1·00 (reference)   
  II                       0·99 (0·77, 1·30)   0·990
  III                      1·31 (1·09, 1·78)   0·009
  IV                       1·98 (1·27, 3·64)   0·026
  COPD                     1·21 (1·02, 1·45)   0·031
  History of arrhythmia    1·25 (1·01, 1·55)   0·044
  Diabetes mellitus        1·26 (1·06, 1·49)   0·009
  Tumour location                             
  Proximal                 1·86 (1·25, 2·77)   0·022
  Middle                   1·07 (0·87, 1·32)   0·514
  Distal                   1·00 (reference)   

Values in parentheses are 95 per cent confidence intervals. COPD, chronic obstructive pulmonary disease.

Discussion {#bjs10728-sec-0014}
==========

This nationwide multicentre cohort study compared clinical outcome in patients with an intrathoracic *versus* cervical anastomosis following oesophagectomy. An intrathoracic anastomosis was associated with lower rates of anastomotic leak and recurrent nerve paresis. This may explain the observed shorter duration of hospital stay among patients with an intrathoracic anastomosis than for those with a cervical anastomosis. However, among patients with an anastomotic leak, ICU and hospital stay was longer in the group with an intrathoracic anastomosis. Independent risk factors for anastomotic leakage include an ASA fitness grade of III or IV, history of cardiac arrhythmia, COPD, diabetes mellitus and proximally located tumours.

Four RCTs[18](#bjs10728-bib-0018){ref-type="ref"}, [19](#bjs10728-bib-0019){ref-type="ref"}, [20](#bjs10728-bib-0020){ref-type="ref"}, [21](#bjs10728-bib-0021){ref-type="ref"} have investigated clinical outcome in patients with an intrathoracic or cervical anastomosis. The results of these studies are equivocal regarding which anastomotic technique is preferred in reducing the risk of anastomotic leakage. The conflicting results can be explained by these studies being underpowered, with few events (range 2--13 per study), resulting in uncertain estimates. Other methodological shortcomings are the large degree of variation in surgical approaches, definitions of anastomotic leakage, and variation in stapled and hand‐sutured anastomosis. Two meta‐analyses[15](#bjs10728-bib-0015){ref-type="ref"}, [28](#bjs10728-bib-0028){ref-type="ref"}, including 298 patients, found that anastomotic leakage occurred less often after an intrathoracic anastomosis than a cervical anastomosis. The present results are in line with these analyses.

Although the anastomotic leak rate was lower in patients with an intrathoracic anastomosis, and this may appear the preferred location of the oesophagogastric anastomosis, leak rates in the present study are high compared with those in other studies[5](#bjs10728-bib-0005){ref-type="ref"}, [9](#bjs10728-bib-0009){ref-type="ref"}. Leak rates after an intrathoracic and cervical anastomosis range from 9 to 21 per cent[9](#bjs10728-bib-0009){ref-type="ref"}, [17](#bjs10728-bib-0017){ref-type="ref"}, [29](#bjs10728-bib-0029){ref-type="ref"}, [30](#bjs10728-bib-0030){ref-type="ref"} and 8 to 35 per cent[9](#bjs10728-bib-0009){ref-type="ref"}, [17](#bjs10728-bib-0017){ref-type="ref"}, [29](#bjs10728-bib-0029){ref-type="ref"}, [31](#bjs10728-bib-0031){ref-type="ref"} respectively. Some studies included only clinically relevant or radiologically proven anastomotic leaks, whereas others included both[32](#bjs10728-bib-0032){ref-type="ref"}. This discrepancy in definitions makes it difficult to compare leak rates between studies. In the present study, the definition of anastomotic leakage remained the same throughout the study, and included (subtle) clinical and radiological signs of leakage.

Between 2011 and 2016, some centres moved from a cervical to an intrathoracic anastomosis; 20·6 per cent of anastomoses were intrathoracic in 2011 and 59·3 per cent in 2015. The introduction of an intrathoracic anastomosis is associated with a learning curve[33](#bjs10728-bib-0033){ref-type="ref"}, [34](#bjs10728-bib-0034){ref-type="ref"}. Furthermore, the proportion of minimally invasive procedures increased from 53·1 to 85·4 per cent during the study period. The introduction of minimally invasive oesophagectomy is also associated with a learning curve when looking at reinterventions, morbidity and mortality[35](#bjs10728-bib-0035){ref-type="ref"}, [36](#bjs10728-bib-0036){ref-type="ref"}. Although there were no differences in year of surgery and type of surgery between the groups after propensity score matching, a potential learning curve may explain the high leak rate in the present study.

Despite a reduced risk of leakage and shorter hospital stay after an intrathoracic anastomosis, some surgeons prefer a cervical anastomosis. The possibility of a wider resection margin and less severe complications in patients with an anastomotic leak are claimed benefits of a cervical anastomosis[37](#bjs10728-bib-0037){ref-type="ref"}. The present study demonstrated that an anastomotic leak in a patient with an intrathoracic anastomosis led to a longer intensive care and hospital stay. This suggests that the clinical course in patients with an intrathoracic anastomotic leak is indeed more severe[38](#bjs10728-bib-0038){ref-type="ref"}. There were no differences in R0 resection rates, surgical reinterventions and postoperative mortality between intrathoracic and cervical anastomoses. The safety of the intrathoracic technique is supported by a recent meta‐analysis[28](#bjs10728-bib-0028){ref-type="ref"} that found no difference in in‐hospital mortality between intrathoracic and cervical anastomoses.

Previous studies[9](#bjs10728-bib-0009){ref-type="ref"}, [15](#bjs10728-bib-0015){ref-type="ref"}, [28](#bjs10728-bib-0028){ref-type="ref"}, [39](#bjs10728-bib-0039){ref-type="ref"} have defined factors associated with anastomotic leakage after an intrathoracic anastomosis. Factors resulting in poor tissue perfusion and vascular impairment are considered important[5](#bjs10728-bib-0005){ref-type="ref"}, [9](#bjs10728-bib-0009){ref-type="ref"}, [10](#bjs10728-bib-0010){ref-type="ref"}, [40](#bjs10728-bib-0040){ref-type="ref"}. This is in accordance with the present findings, as COPD, diabetes mellitus, ASA grades of III and IV, and proximal tumours were identified as independent risk factors for the development of anastomotic leakage. Although the present study did not identify risk factors other than those already described in the literature, these findings suggest that it may be important to improve the preoperative physical status of high‐risk patients before oesophagectomy.

Strengths of this study include the population‐based design, the adjustment for important confounders, and the relatively large sample size. Furthermore, data from the DUCA are collected prospectively, and controlled for completeness and validity by an independent monitoring team. There are also limitations to this study, including its retrospective design and lack of randomization. Although propensity score matching was performed, the inability of propensity score matching to adjust for unknown confounders (such as surgical decision‐making) is a limitation. Details of anastomotic techniques that may influence the healing of the anastomosis are not recorded in the DUCA. In addition, centre‐ and surgeon‐specific data on leak rates were not available for the purpose of this study, although these data are available for the individual centres. At present, a randomized trial[41](#bjs10728-bib-0041){ref-type="ref"} comparing the intrathoracic and cervical approach is under way that should resolve these limitations and make an important contribution to the current literature.
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